Corrigendum: OIT3 serves as a novel biomarker of hepatocellular carcinoma by mediating ferroptosis via regulating the arachidonic acid metabolism

• Jie Wen,
• Abudureyimujiang Aili,
• Yao Xue Yan,
• YuLin Lai,
• Shaoqing Niu,
• Shasha He,
• Xiaokai Zhang,
• Guixiong Zhang,
• Jiaping Li

Affiliations

Jie Wen

Department of Interventional Oncology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China and Department of Medical Oncology and Radiation Sickness, Peking University Third Hospital, Beijing, China

Abudureyimujiang Aili

Department of Medical Oncology and Radiation Sickness, Peking University Third Hospital, Beijing, China

Yao Xue Yan

Department of Dermatology, Peking University People’s Hospital, Beijing, China

YuLin Lai

Deparment of Radiotherapy, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

Shaoqing Niu

Deparment of Radiotherapy, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

Shasha He

Deparment of Radiotherapy, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

Xiaokai Zhang

Department of Interventional Oncology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

Guixiong Zhang

Department of Interventional Oncology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

Jiaping Li

Department of Interventional Oncology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China